Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06577480
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-08-27
Brief Title:
Validity and Reliability of the Turkish Version of the Post-Liver Transplant Quality of Life Questionnaire
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Investigation of Validity and Reliability of the Turkish Version of the Post-Liver Transplant Quality of Life pLTQ Questionnaire
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Liver transplantation is a crucial treatment for life-threatening liver diseases including acute liver failure end-stage chronic liver disease primary liver cancers and congenital metabolic disorders Quality of life in liver transplant patients is vital The World Health Organization defines quality of life as an individuals perception of their position in life within the context of culture values goals and expectations Liver transplantation improves quality of life Recipients should be closely monitored and supported psychologically with the effectiveness of the intervention in improving quality of life well-documented Saab et al developed the post-Liver Transplantation Quality of Life pLTQ questionnaire which includes eight sub-dimensions across 32 items To our knowledge no Turkish-specific QoL tool for liver transplant patients currently exists This study aims to validate and assess the reliability of the Turkish version of the pLTQ questionnaire
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None